loadpatents
name:-0.01767897605896
name:-0.0061051845550537
name:-0.00047993659973145
Schiffman; Rhett Patent Filings

Schiffman; Rhett

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schiffman; Rhett.The latest application filed is for "ocular implant and delivery system".

Company Profile
0.6.19
  • Schiffman; Rhett - Irvine CA
  • Schiffman; Rhett - Laguna Beach CA
  • Schiffman; Rhett - Morrisville NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Ocular Implant And Delivery System
App 20210030590 - Blanda; Wendy ;   et al.
2021-02-04
Preservative free bimatoprost and timolol solutions
Grant 10,058,560 - Likitlersuang , et al. August 28, 2
2018-08-28
Preservative Free Bimatoprost And Timolol Solutions
App 20180185385 - Likitlersuang; Sukhon ;   et al.
2018-07-05
Implant For Treatment Of An Ocular Condition
App 20180177718 - Garcia; Andres ;   et al.
2018-06-28
Prevention and treatment of ocular side effects with a cyclosporin
Grant 9,839,667 - Feinerman , et al. December 12, 2
2017-12-12
Preservative free bimatoprost and timolol solutions
Grant 9,763,958 - Likitlersuang , et al. September 19, 2
2017-09-19
Cyclosporin compositions
Grant 9,561,178 - Graham , et al. February 7, 2
2017-02-07
Preservative Free Bimatoprost And Timolol Solutions
App 20150224115 - Likitlersuang; Sukhon ;   et al.
2015-08-13
Preservative free bimatoprost and timolol solutions
Grant 9,061,034 - Likitlersuang , et al. June 23, 2
2015-06-23
Preservative Free Bimatoprost And Timolol Solutions
App 20140256726 - Likitlersuang; Sukhon ;   et al.
2014-09-11
Prevention And Treatment Of Ocular Side Effects With A Cyclosporin
App 20140038905 - Feinerman; Gregg ;   et al.
2014-02-06
Prevention And Treatment Of Ocular Side Effects With A Cyclosporin
App 20140038904 - Feinerman; Gregg ;   et al.
2014-02-06
Prevention And Treatment Of Ocular Side Effects With A Cyclosporin
App 20140030226 - Feinerman; Gregg ;   et al.
2014-01-30
Prevention And Treatment Of Ocular Side Effects With A Cyclosporin
App 20140010846 - Feinerman; Gregg ;   et al.
2014-01-09
Prevention And Treatment Of Ocular Side Effects With A Cyclosporin
App 20140011750 - Feinerman; Gregg ;   et al.
2014-01-09
Prevention And Treatment Of Ocular Side Effects With A Cyclosporin
App 20140011751 - Feinerman; Gregg ;   et al.
2014-01-09
Prevention And Treatment Of Ocular Side Effects With A Cyclosporin
App 20140011752 - Feinerman; Gregg ;   et al.
2014-01-09
Prevention And Treatment Of Ocular Side Effects With A Cyclosporin
App 20130345148 - Feinerman; Gregg ;   et al.
2013-12-26
Prevention And Treatment Of Ocular Side Effects With A Cyclosporin
App 20130345147 - Feinerman; Gregg ;   et al.
2013-12-26
Cyclosporin Compositions For Ocular Rosacea Treatment
App 20080207495 - Graham; Richard S. ;   et al.
2008-08-28
Cyclosporin Compositions
App 20080146497 - Graham; Richard S. ;   et al.
2008-06-19
Brimonidine And Timolol Compositions
App 20080051406 - Graham; Richard ;   et al.
2008-02-28
Cyclosporin Compositions
App 20080039378 - Graham; Richard S. ;   et al.
2008-02-14
Compositions and methods comprising memantine and polyanionic polymers
App 20050031652 - Hughes, Patrick M. ;   et al.
2005-02-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed